GLP-1 Check-up: What Doctors Really Think About New Weight Loss Drugs
Wednesday, July 31, 11am PT / 2pm ET
Register to attend live or get the replay
Everyone’s talking about GLP-1s. But what about the providers writing the prescriptions? What do they think about GLP-1s for weight loss?
A new survey of 300 PCPs, endocrinologists and obesity-certified specialists explores what’s really happening within the four walls of the doctors office between the patients asking for weight loss drugs and the providers trying to support them.
Join this webinar to get this new data, including:
- Why providers say GLP-1s are an imperfect solution for obesity
- Patient’s unrealistic expectations of weight loss drugs
- Why they say GLP-1s are used too frequently for obesity and why lifestyle programs should be a first line therapy
- What kind of support providers want as they navigate the GLP-1 wave
Register to save your spot or get a copy of the recording and survey report after the live webinar.
Register for the webinar
Featured Speakers
Frank Dumont, MD, FACP
Medical Director, Virta Health
Dr. Frank Dumont currently serves as a clinician and Commercial Medical Director at Virta Health. Prior to joining Virta, he worked in a hospital-owned clinic for nearly 20 years, where he practiced outpatient and inpatient medicine and served as medical director of the wellness service line for the medical center.
Jonathan Pearlstein
VP, Market Strategy and Development, Virta Health
Jonathan Pearlstein currently serves as the VP of Market Strategy & Development at Virta Health, the leader in type 2 diabetes reversal. Prior to Virta, he led go-to-market teams at Jiff & Castlight Health. Before that he was a consultant at McKinsey as well as at The Advisory Board Company, where he served health plan and health system clients. Jonathan holds an MBA from The Wharton School and a BA from Stanford University.
Greeshma Shetty, MD
Director of Quality and Safety, Virta Health
Dr. Greeshma Shetty, board certified in Internal Medicine and Endocrinology, currently serves as a Lead Clinician in the Virta Medical Group and the Director of Quality and Safety at Virta Health. Prior to joining Virta, she was physician educator at Harvard Medical School, where she directed the combined Joslin - Beth Israel Deaconess Endocrine Fellowship program and co-directed the Asian American Diabetes Initiative. She is dedicated to clinical excellence, leveraging health technology, transforming healthcare delivery, driving health equity and building high performing teams.
Copyright © 2024 All Rights Reserved